Drug Reduces Mysterious Particle Involved in Heart Attack Risk
The Eli Lilly drug caused a major drop in the blood levels of Lp(a), but further research is needed to show that it will ...
The American Journal of Managed Care4h
Abelacimab Shows Unprecedented Bleeding Risk Reduction in Patients With Atrial Fibrillation
Christian T. Ruff, MD, MPH, of Brigham and Women's Faulkner Hospital, discusses new data comparing abelacimab with ...
AFib diagnosed in midlife linked to 21% increased risk of dementia at any age, 36% higher risk of early-onset dementia
New research presented at the EHRA 2025, a scientific congress of the European Society of Cardiology, shows that the presence ...